Oncology Nursing News®

Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

Lung Cancer

FDA Grants Full Approval to Combination Use of Pembrolizumab, Chemotherapy for NSCLC

FDA Grants Full Approval to Combination Use of Pembrolizumab, Chemotherapy for NSCLC

BY JASON M. BRODERICK

FDA Approves Nivolumab for Small Cell Lung Cancer

FDA Approves Nivolumab for Small Cell Lung Cancer

BY JASON M. BRODERICK

Lung Cancer Risk Among Heavy Smokers Who Quit

Lung Cancer Risk Among Heavy Smokers Who Quit

BY LISA SCHULMEISTER, MN, RN, FAAN

CURE Media Group Expands Strategic Alliance Partnership Program with Lung Cancer Alliance

CURE Media Group Expands Strategic Alliance Partnership Program with Lung Cancer Alliance

BY STAFF

FDA Grants Priority Review to Frontline Pembrolizumab Combo in Metastatic NSCLC

FDA Grants Priority Review to Frontline Pembrolizumab Combo in Metastatic NSCLC

BY KRISTIE L. KAHL

LUNGevity Takes Step Forward in Clinical Trial Eligibility Reform for Lung Cancer Patients

LUNGevity Takes Step Forward in Clinical Trial Eligibility Reform for Lung Cancer Patients

BY LUNGEVITY

Next-Generation Sequencing Found to Be Most Cost-Effective in Advanced NSCLC

Next-Generation Sequencing Found to Be Most Cost-Effective in Advanced NSCLC

BY ANGELICA WELCH

FDA Grants Breakthrough Designation to Crizotinib for Lung Cancer, Lymphoma Subtypes

FDA Grants Breakthrough Designation to Crizotinib for Lung Cancer, Lymphoma Subtypes

BY JASON M. BRODERICK

Clinical Insights: May 2018

Clinical Insights: May 2018

FDA Grants Priority Review to Atezolizumab Combo as First-Line Treatment for NSCLC

FDA Grants Priority Review to Atezolizumab Combo as First-Line Treatment for NSCLC

BY JASON M. BRODERICK

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.